Uridine adenosine tetraphosphate

• Description:

  Uridine adenosine tetraphosphate (UP4A) is an endothelium-derived vasoconstrictor that primarily acts through the P2X1 receptor and possibly through the P2Y2 and P2Y4 receptors. Uridine adenosine tetraphosphate can be used in the study of cardiovascular diseases[1].

• Product Name Alternative:

  UP4A

• UNSPSC:

  12352005

• Target:

  P2X Receptor

• Related Pathways:

  Membrane Transporter/Ion Channel

• Field of Research:

  Cardiovascular Disease

• Smiles:

  O[C@H]1[C@@H] (O) [C@H] (N (C=N2) C3=C2C (N) =NC=N3) O[C@@H]1COP (OP (OP (OP (OC[C@@H]4[C@@H] (O) [C@@H] (O) [C@H] (N5C=CC (NC5=O) =O) O4) (O) =O) (O) =O) (O) =O) (O) =O

• Molecular Formula:

  C19H27N7O21P4

• Molecular Weight:

  813.35

• References & Citations:

  [1]Jankowski, et al. "Uridine adenosine tetraphosphate: a novel endothelium-derived vasoconstrictive factor." Nature medicine 11.2 (2005) : 223-227.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  10527-48-7